American Century Companies’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
SW
VCM
TCM
American Century Companies's NAGE Position: Q1 2026 in Review
American Century Companies reduced its Niagen Bioscience (NAGE) stake by 47% in Q1 2026, selling an estimated $357K and leaving 74,490 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2618.
American Century Companies first reported a position in NAGE in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.38M in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.
- American Century Companies held 74,490 shares of Niagen Bioscience worth $329K as of Q1 2026.
- American Century Companies sold 66,178 Niagen Bioscience shares in Q1 2026, an estimated $357K.
- Niagen Bioscience made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2618 holding.
- American Century Companies first reported a position in Niagen Bioscience in Q1 2025 and has held it in 5 quarters since.
- American Century Companies's Niagen Bioscience position peaked at $1.38M in Q2 2025.
- 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.